.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

CLL

EP. 1: ASH 2020: Results From the Phase 1/2 BRUIN Trial

April 23rd 2021

EP. 2: ASH 2020: TRANSCEND-CLL-004 Study: Results of CAR-T Combination in R/R CLL or SLL

April 23rd 2021

EP. 3: ASH 2020: TRANSCEND-CLL-004 Study: Results of CAR-T Monotherapy in R/R CLL or SLL

April 23rd 2021

EP. 4: ASH 2020: Results From the UNITY-CLL Study of Ublituximab Doublet Versus Chemoimmunotherapy in CLL

April 23rd 2021

EP. 5: Results From the Phase 2 CAPTIVATE Study

April 23rd 2021

EP. 6: ASH 2020: Updated Results from the Murano Five-Year Analysis in R/R CLL

April 23rd 2021

Latest News

Healthy Habits May Offset Genetic Cancer Risk

Expert Explains Prognosis Indicators, Treatment Plans in MCL

Smoking Cessation May Provide ‘Huge Benefit’ After Lung Cancer Diagnosis

The Game of Cancer

View More Latest News